MICHAEL VASCONCELLES - 15 Aug 2022 Form 4 Insider Report for Magenta Therapeutics, Inc. (DNTH)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for Michael Vasconcelles
Issuer symbol
DNTH
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 08:19:02 UTC
Next filing
03 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNTH Stock Option (Right to Buy) Award $0 +40,000 $0.000000 40,000 15 Aug 2022 Common Stock 40,000 $1.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable over three years, with 33% of this option vesting on August 15, 2023, and the remainder vesting in 24 equal monthly installments thereafter.